Association of PD ‐L1 expression with treatment outcomes in patients with BRAF mutation–positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib

This article is protected by copyright. All rights reserved.

Source: Pigment Cell Research - November 20, 2017 Category: Cytology Authors: Matthew J. Wongchenko, Antoni Ribas, Brigitte Dr éno, Paolo A. Ascierto, Grant A. McArthur, Jorge D. Gallo, Isabelle A. Rooney, Jessie Hsu, Hartmut Koeppen, Yibing Yan, James Larkin Tags: Original Article Source Type: research